48,460
edits
Difference between revisions of "Placenta"
Jump to navigation
Jump to search
m
→Villitis of unknown etiology
(→Fetal thrombotic vasculopathy: +images) |
|||
| Line 541: | Line 541: | ||
*Prevalence: 5% to 15% of all placentas. | *Prevalence: 5% to 15% of all placentas. | ||
*Associated with: | *Associated with: | ||
**Intrauterine growth restriction. | **[[Intrauterine growth restriction]] (IUGR). | ||
**Recurrent reproductive loss/adverse outcomes in subsequent pregnancies -- '''key point'''. | **Recurrent reproductive loss/adverse outcomes in subsequent pregnancies -- '''key point'''. | ||
***Recurrence in up 37% of cases.<ref name=pmid20604650>{{cite journal |author=Feeley L, Mooney EE |title=Villitis of unknown aetiology: correlation of recurrence with clinical outcome |journal=J Obstet Gynaecol |volume=30 |issue=5 |pages=476–9 |year=2010 |pmid=20604650 |doi=10.3109/01443611003802339 |url=}}</ref> | ***Recurrence in up 37% of cases.<ref name=pmid20604650>{{cite journal |author=Feeley L, Mooney EE |title=Villitis of unknown aetiology: correlation of recurrence with clinical outcome |journal=J Obstet Gynaecol |volume=30 |issue=5 |pages=476–9 |year=2010 |pmid=20604650 |doi=10.3109/01443611003802339 |url=}}</ref> | ||